ABX196 for use in the treatment of bladder cancer
US11266667B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2018 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Dec 17, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound ABX196 and pharmaceutical compositions including ABX196 are used in the treatment of bladder cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.